A new study has been published on Bactiguard’s endotracheal tube (BIP ETT) that shows a significant reduction of both ventilator-associated pneumonia (VAP) and antibiotic use. This randomized controlled study on 180 intensive care patients was published in the Balcan Medical Journal, in March 2022. The main objective of the study was to evaluate...
A new study from Liège, Belgium, shows that the usage of Bactiguard’s infection preventive endotracheal tube reduces ventilator associated pneumonia (VAP) with 53% in intensive care patients. The study VITAL was presented in the beginning of October at the European Society of Intensive Care Medicine Congress (ESICM) where it was selected as one...
A new American study concludes that healthcare associated infections (HAI) increased in the US during the COVID-19 pandemic. Infections related to the urinary tract, respiratory tract and blood stream all raised, for instance, central line associated bloodstream infections (CLABSI) increased with 46-47%. The intention of the study was to...
Sepsis is the number one preventable cause of death in the world, but very few people know what it is and what the consequences are. Every year, around 49 million people suffers from sepsis and 11 million don’t survive. To raise awareness about how to prevent and identify signs of sepsis, World Sepsis Day takes place every year on September...
Overuse of antibiotics and superbugs could be worsening the Covid-19 pandemic in India, according to an Indian Council of Medical Research (ICMR) study of 10 hospitals. The study showed that more than half of the Covid-19 patients who get a secondary bacterial or fungal infection die. Covid-19 mortality worldwide is 10 %, the subgroup of patients...
Antibiotic resistance is one of the most acute health risks of our time. The threat is often referred to as "the silent tsunami" and could potentially nullify hundreds of years of medical progress, according to the WHO. To counteract the resistance, we need to prevent infections in healthcare and in our everyday lives - a challenge for which the...
A recent Italian publication has studied hospital-acquired infections (HAI) in critically ill COVID-19 patients. 774 patients with COVID-19 treated at intensive care unit (ICU) at 8 hospitals in Italy were included. The publication1 shows that 46 % of the critically ill COVID-19 patients developed HAI, of which 38 % were caused by multi-drug...
Yesterday the first joint working group of the “Healthcare associated infection – Vision zero for India” platform was held. Significant progress was made in the journey towards establishing a solid platform for reaching the goal of “zero healthcare-associated infections (HAI)” in India. The initiative is built on a triple helix model...
Bactiguard is a Swedish medtech company with a global presence, offering prevention solutions for nosocomial infections, reducing the use of antibiotics and the spread of multi-resistant bacteria. In this article, its CEO Christian Kinch, explains how Bactiguard’s solution works to save lives and reduce healthcare costs. He also shares the...
In an imagined scenario from 2041 the Economist describes how the world belatedly responded to antimicrobial resistance. If antibiotics stop working, the superbugs will spread rapidly. According to a study published in the scientific journal The Lancet1 in November 2018 more than 33,000 people die in Europe every year as a direct consequence of...
In an interview with Times of India, Lena Hallengren, the Swedish minister of Social Affairs mentions Bactiguard as one of the Swedish companies contributing to developing the healthcare sector in India. On a delegation trip to India the national magazine Times of India made an interview with the Swedish minister of Social Affairs, Lena...
The on-going annual World Antibiotic Awareness Week is a WHO initiative to put antibiotic resistance (AMR) in the spotlight and increase awareness. It also aims to encourage best practices to avoid the further emergence and spread of AMR. Now everyone can learn more trough an interactive game developed by the WHO. Our time with antibiotics is...
Modern, advanced healthcare is dependent on effective antibiotics. But incorrect and excessive use of antibiotics has allowed resistant bacteria to spread rapidly throughout the world. If this development doesn’t halt, common infections will be hard to treat and even become incurable. Premature care is an example where multi-resistant bacteria...
Sepsis remains the primary cause of death from infections around the world, despite advances in modern medicine such as vaccines and antibiotics. Every 3-4 seconds someone dies of sepsis. The World Sepsis Day is held on September 13th every year and is an opportunity for people across the world to unite in the fight against sepsis. Bactiguard is...
Yesterday at the ongoing "Urologidagarna" (Urology Days), arranged by the Swedish Urological Society, a Swedish study was presented about Bactiguard's Infection Protection Foley Catheter Silicone (BIP Foley). The study shows that 28 out 31 patients, who switched from a standard catheter to the BIP Foley Catheter, felt that the change led to both...
On June 29, 2017, the prestigious New England Journal of Medicine published an article detailing the Global Sepsis Alliance’s (GSA) perspective on the World Health Organization (WHO) resolution on improving the prevention, diagnosis, and management of sepsis. The term “sepsis” dates to at least the time of Hippocrates, who considered it the...
On 26 May 2017, the World Health Organization (WHO) agreed on a resolution to improve the prevention, diagnosis and treatment of sepsis. The resolution urges governments to strengthen their policies in infection prevention and to decrease the spread of antimicrobial resistance. The resolution itself focuses on the following key preventive actions:...
Bactiguard is now a proud sponsor of World Sepsis Day initiated by the Global Sepsis Alliance. Sepsis is the main cause of death from infection and affects more than 30 million people a year; of whom 6 to 8 million die. In Sweden, almost 40,000 people suffer from sepsis per year.[1] Surviving patients suffer from the consequences for the rest of...
A recent in-depth review published in the Journal of the Pediatric Infectious Diseases Society (Oxford University Press) has identified extremely high rates of antimicrobial resistance to bloodstream infections in neonates and children in India. In a survey of over 50,000 reported blood cultures, almost one-third (29.1%) were positive for...
In Life Science Sweden Issue No 1 March 2017, Bactiguard’s CEO Christian Kinch presents our simple idea: Preventing Health Care related infections caused by medical devices. Read the article
A study published by The Lancet Infectious Diseases found that the prevalence of healthcare-associated infections (HAI) was the highest in pediatric intensive care units (ICUs) with one in six children having an infection. In neonatal ICUs, 1 in 10 babies were infected. The study was based on data from the European Center for Disease Control...
Urinary tract infections resulting from the use of indwelling urinary catheters are one of the most common healthcare associated infections, causing patient suffering and a large financial strain on healthcare systems. These infections can also result in more serious complications such as bloodstream infections with high mortality rates. These...
This week is the annual International Infection Prevention Week (IIPW), , and aims to raise awareness of the role infection prevention plays in improving patient safety. IIPW is organized by the US-based Association for Professionals in Infection Control and Epidemiology (APIC) which is the leading professional association for infection...
World Sepsis Day, on September 13, is a collaborative project organized by the Global Sepsis Alliance and relevant non-governmental stakeholders with the aim of raising awareness on one of the most common yet least-recognized illnesses. Sepsis is the main cause of death from infection and kills more people than cancer in the developed world.[1]...
Bactiguard and BioInteractions have received a European research grant aimed at developing a new generation of vascular access catheters, with new bio-smart materials for medical devices. The technology will be developed in a joint project with BioInteractions, UK and Bactiguard, financed by VINNOVA and Innovate UK. Some of the most serious...
About three hundred urologists visited Bactiguard’s booth at EAU, Europe’s biggest congress for doctors specialized in urology. Several of them expressed a great need for a solution reducing the number of catheter associated urinary tract infections (CAUTI), which often occur when patients are using a urinary catheter for a longer time. During...
The healthcare costs in Colombia are increasing and the need for infection control, such as Bactiguard’s infection preventive solution, is becoming a more prioritized area. In February Bactiguard and Business Sweden jointly visited Colombia aiming to network and establish relationships with decision makers and potential customers in the...
The annual World Kidney Day is arranged on March 10, to increase awareness about the chronic kidney disease, which is a worldwide disease affecting millions of patients. In connection to this, the newspaper The Parliament Magazine has published several articles about kidney diseases, including a presentation the DIREKT project, also involving...
Bactiguard won a tender, to supply urinary tract catheters to the Swedish region Halland. This means that Halland is able to start to purchase Bactiguard’s Infection Protection Foley catheters from 1 October 2016. ”In the past year we have been working methodically to demonstrate the value of our technology and our infection prevention urinary...
Following the Chinese approval of Bactiguard’s Foley catheters for infection prevention, which was recently announced, the company has received an initial order of 100,000 catheters. In January 2016, the doors were opened to China, one of the largest and fastest growing markets in the world, with the approval of the company’s Foley catheter...
This week, Bactiguard hosted a Peruvian healthcare delegation, studying the benefits of the Swedish triple helix model, i.e. the interaction between the healthcare system, academia and industry. The Peruvian delegation, organized by Business Sweden, consisted of representatives of the Ministry of Health and doctors from the National Cancer...
The 11th edition of the Swedish American Life Science Summit in Stockholm took place on August 19-21, gathering scientists, doctors, industry representatives and investors from around the world. The main purpose of the annual conference is to create business opportunities and exchange ideas between the participants, transforming research to...
Billy Södervall acquired his interest in chemistry and pharmacy early on. He started teaching chemistry and then he went over to working with heat pumps at NIBE AB, where he created the innovation that formed the foundation for Bactiguard. Billy always felt his work was also his hobby, explaining why his garage at home in Markaryd is converted...
It´s summer time, vacation is approaching and many travel abroad. If you are planning a trip, there are some things to consider to be on the safe side. Hospital acquired infections (HAI) and the spread of multi resistant bacteria is a global problem affecting us all, where we live and while travelling you expose yourself to an increased risk of...
Every year, as many as 500 000 people die from common infections, as they can no longer be treated with antibiotics due to antimicrobial resistance. This situation also has an impact on the economy, with a cost of about 1.5 billion euro for increased healthcare cost and loss of productivity in the EU alone. And the problem is steadily growing....
Good hand hygiene is essential to avoid infections and can reduce healthcare associated infections and, most important of all, save millions of lives. Today May 5 is the annual Save Lives: Clean your hands campaign, initiated by the World Health Organization (WHO) aiming to increase awareness about the importance of hand hygiene in order to save...
Healthcare associated infections (HAI) are common in Romania, like in the rest of the world. Ventilator associated pneumonia (VAP) is a particularly serious condition, which Bactiguard’s technology can prevent. Together with our distributor Alpha Medical, we are well equipped to prevent and combat this severe problem in Romania. This week we...
Infectious diseases, caused by antibiotic resistant bacteria, are a steadily increasing problem around the world. The consequences are huge, both from a human and economic perspective. If action is not taken, about ten million lives are at risk and cost is expected to reach above 100 trillion USD in 2050. This is stated in the report “Review on...
Latin America and the imminent sales start in Chile and Brazil was the focus of Bactiguard’s attention in the second week of October. In March 2014, Bactiguard signed an exclusive distribution agreement with Promedon for Argentina, Brazil, Chile and Mexico and now, two of these markets are ready to launch. A two-day interactive sales training...
The Bactiguard technology has been clinically proven to reduce catheter-related urinary tract infections and is by far the most well documented and effective technology that I know of, says Dr William R Jarvis, one of the authors behind the most recently performed study and previously active at the CDC for many years. Bactiguard has a patented...
Innovative coating makes hospitals healthier Bactiguard started in 2005 with one mission: to reduce hospital-acquired infections (HAI) transmitted through medical devices. Its innovative technology is based on the Swedish industrialist Gustaf Dalén’s Nobel Prize-winning research from 1912, on automatic regulators for use in conjunction with gas...
Health Care Assoicated Infections can be prevented. Watch this movie http://www.youtube.com/watch?v=yYpKESbVYvI&feature=youtu.be to see how the Bactiguard coating prevents bacteria and saves lives !
The Swedish Medtech company Bactiguard has made its full portfolio of infection protection products available in Middle East markets. In addition to the BIP Foley Catheters that are already available, Bactiguard´s BIP Endotracheal Tube and BIP Central Venous Catheter will now be introduced. The new products will be sold through Gulf Medical...
Bactiguard is now starting to supply its own urinary catheter, BIP Foley, to the Swedish healthcare system, with the goal of radically reducing one of medical care’s most difficult problems – unnecessary suffering and, in certain cases, premature death due to hospital acquired infections (HAI), also known as nosocomial infections. BIP Foley...